← Open Payments lookup

CLYDE MARQUIS: Open Payments

NPI 1619270998 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,487 in 72 payments from 13 companies in 2025. Trend: 2023 $512 · 2024 $940 · 2025 $2,487

Food & beverage: $2,487
CompanyPaymentsAmount
AOP Health US, LLC1$785
GlaxoSmithKline, LLC.27$569
Verona Pharma, Inc.13$230
AstraZeneca Pharmaceuticals LP6$165
GENZYME CORPORATION7$162
ABIOMED1$121
Lilly USA, LLC1$113
Regeneron Healthcare Solutions, Inc.5$111
Viatris Specialty LLC4$84
Actelion Pharmaceuticals US, Inc.4$75

Products named: Rapiblyk, NUCALA, DUPIXENT, Ohtuvayre, TRELEGY ELLIPTA, ZEPBOUND, YUPELRI, TEZSPIRE.

Industry payments across TX — which companies pay providers there.